Activation of the Unfolded Protein Response with the First-in-Class P97 Inhibitor CB-5083 Induces Stable Disease Regression and Overcomes Ara-C Resistance in AMLSteffan T. Nawrocki, Jennifer S. Carew, Bartlomiej Przychodzen et al.|Blood|2015Cited by 1
Inhibition of p97 with the First-in-Class Small Molecule CB-5083: A Novel Strategy for Acute Myeloid Leukemia TherapyRita Tohmé, Jennifer S. Carew, Ronan Le Moigne et al.|Blood|2014Cited by 0